ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,870.62
      -1.32%
      US Tech 100
      19,880.00
      -2.30%
      Dow Jones
      43,444.99
      -0.70%
      Brent Oil
      71.25
      0.50%
      Bitcoin
      91,400.72
      0.37%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Eliem Therapeutics Inc (ELYM) Quote

      Eliem Therapeutics Inc

      Eliem Therapeutics Inc (ELYM)

      NASDAQ
      5.11
      0.00
      (0.00%)
      Closed November 16 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      5.11
      Bid
      4.90
      Ask
      5.30
      Volume
      -
      0.00 Day's Range 0.00
      2.35 52 Week Range 11.55
      Market Cap
      342.677M
      Previous Close
      5.11
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      404,295
      Shares Outstanding
      67,060,163
      Dividend Yield
      -
      PE Ratio
      -9.76
      Earnings Per Share (EPS)
      -0.52
      Revenue
      -
      Net Profit
      -35.12M

      About Eliem Therapeutics Inc

      Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      climbbio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Eliem Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELYM. The last closing price for Eliem Therapeutics was $5.11. Over the last year, Eliem Therapeutics shares have traded in a share price range of $ 2.35 to $ 11.55.

      Eliem Therapeutics currently has 67,060,163 shares outstanding. The market capitalization of Eliem Therapeutics is $342.68 million. Eliem Therapeutics has a price to earnings ratio (PE ratio) of -9.76.

      Ask ADVFN Intelligence (AI)

      ELYM Latest News

      More News

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form S-3 - Registration statement under Securities Act of 1933

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 15 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 02 2024
      Edgar (US Regulatory)

      Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

      Name change to "Climb Bio" marks the Company’s transition and focus on developing treatments for immune-mediated diseases Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM...

      October 02 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      September 20 2024
      Edgar (US Regulatory)

      Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit

      SEATTLE and CAMBRIDGE, United Kingdom, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the management team will participate at the Stifel...

      September 11 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1005.115.115.1100CS
      4005.115.115.1100CS
      12-0.66-11.438474875.778.794.75214042956.7020465CS
      26-3.48-40.51222351578.599.584.75212840636.96828185CS
      522.54599.22027290452.56511.552.353617295.82426347CS
      156-12.89-71.61111111111819.62.211547785.63090088CS
      260-11.14-68.553846153816.2529.692.211566666.93876442CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CEROCERo Therapeutics Holdings Inc
      $ 0.2853
      (52.40%)
      		1.17B
      CYCNCyclerion Therapeutics Inc
      $ 2.5306
      (42.97%)
      		11.99M
      SPPLSIMPPLE Ltd
      $ 1.2503
      (41.60%)
      		165.69M
      PULMPulmatrix Inc
      $ 6.5586
      (39.54%)
      		5.37M
      ZTEKZentek Ltd
      $ 1.2574
      (29.96%)
      		309.67k
      TFFPTFF Pharmaceuticals Inc
      $ 0.376101
      (-76.49%)
      		9.35M
      EYENEyenovia Inc
      $ 0.10185
      (-70.05%)
      		52.8M
      CTXRCitius Pharmaceuticals Inc
      $ 0.1974
      (-39.89%)
      		11.26M
      VVPRVivoPower International PLC
      $ 0.8151
      (-39.62%)
      		2.34M
      IPWiPower Inc
      $ 0.7302
      (-39.15%)
      		1.15M
      CEROCERo Therapeutics Holdings Inc
      $ 0.2853
      (52.40%)
      		1.15B
      ELABElevai Labs Inc
      $ 0.0211
      (-19.47%)
      		377.69M
      NVDANVIDIA Corporation
      $ 141.98
      (-3.26%)
      		244.07M
      SPPLSIMPPLE Ltd
      $ 1.2503
      (41.60%)
      		164.49M
      STISolidion Technology Inc
      $ 0.44
      (25.71%)
      		139.46M

      ELYM Discussion

      View Posts
      TimeFades TimeFades 1 month ago
      lol pump n dumped . Manipulation atm see what happens next . Interesting
      👍️0
      Lime Time Lime Time 1 month ago
      Good Luck, hope it goes again. Name Change sometimes comes with catalysts
      👍️0
      TimeFades TimeFades 1 month ago
      It had a nice climb at 930 locked in profits. Did not see a sub 5 move coming. Do or die range now
      👍️0
      Lime Time Lime Time 1 month ago
      ELYM to CLYM, 10/3/2024
      👍️0
      TimeFades TimeFades 2 months ago
      In heavy at 5
      👍️0
      Invest-in-America Invest-in-America 2 months ago
      ELYM: Indeed!! (ELYM's CEO told his Barber early today: "Our Firm got a solid buyout offer from Merck --- but DON'T tell anyone, because the PR about same won't be released until just before the Market Open on 9-25-24!!")
      👍️0
      Awl416 Awl416 2 months ago
      What leaked
      👍️0
      Monksdream Monksdream 6 months ago
      ELYM new 52 high
      👍️0
      Monksdream Monksdream 6 months ago
      ELYM new 52 week high
      👍️0
      Monksdream Monksdream 7 months ago
      ELYM under $5
      👍️0
      Monksdream Monksdream 7 months ago
      ELYM new 52 hi
      👍️0
      Awl416 Awl416 7 months ago
      Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
      👍️0
      Monksdream Monksdream 8 months ago
      ELYM under $3
      👍️0
      Monksdream Monksdream 8 months ago
      ELYM 10Q due March 12
      👍️0

      Your Recent History

      NASDAQ
      ELYM
      Eliem Therapeutics
      Delayed Upgrade Clock